Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × copanlisib × Clear all

NCT03803761 2023-09-25

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Phase 1/2 Withdrawn

Brain Neoplasms, Breast Neoplasms